SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-031484
Filing Date
2023-02-10
Accepted
2023-02-10 08:39:58
Documents
1
Group Members
APEIRON PRESIGHT CAPITAL FUND II, L.P.CHRISTIAN ANGERMAYERFABIAN HANSENPRESIGHT CAPITAL MANAGEMENT I, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d398853dsc13ga.htm SC 13G/A 101958
  Complete submission text file 0001193125-23-031484.txt   103725
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93405 | Film No.: 23608663
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

IRS No.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13G/A